Major Depressive
Major depressive disorder as a nonlinear dynamic system: bimodality in the frequency distribution of depressive symptoms over time
... From 1998 to 2003, 267 patients diagnosed with MDD participated in a randomised controlled trial with follow- ups every three months during three years [20, 21]. The study protocol was approved by the Medical Ethics ...
9
Management of Major Depressive Disorder in Prison Populations
... developed major depressive disorder can evolve subacutely over days to weeks, or more slowly after a prodromal period of anxiety and mild depression that lasts for weeks to ...of major ...
39
Body mass index, but not FTO genotype or major depressive disorder, influences brain structure
... Body Mass Index, but not FTO genotype or Major Depressive Disorder, influences brain structure Accepted Manuscript Body Mass Index, but not FTO genotype or Major Depressive Disorder, influ‐ ences brai[.] ...
32
The association between suicide risk and self-esteem in Japanese university students with major depressive episodes of major depressive disorder
... MDe, major depressive episode; BDi-ii, Beck Depression inventory, edition two; Bhs, Beck hopelessness scale; rses, rosenberg’s self-esteem scale; JarT, Japanese adult reading Test; WcsT, Wisconsin card ...
6
Phonologically-based biomarkers for major depressive disorder
... more major depressive episodes (MDEs), where an MDE is defined as a period of at least two weeks during which either a depressed mood dominates or markedly diminished interest, also known as anhedonia, is ...
18
Cortical thickness in youth with major depressive disorder
... Reynolds et al BMC Psychiatry 2014, 14 83 http //www biomedcentral com/1471 244X/14/83 RESEARCH ARTICLE Open Access Cortical thickness in youth with major depressive disorder Stephanie Reynolds1,2, No[.] ...
8
Levomilnacipran for the treatment of major depressive disorder: a review
... Administration for the treatment of major depressive disorder. It is a unique dual neurotransmitter reuptake inhibitor. In contrast with other selective serotonin norepinephrine reuptake inhibitors, ...
11
Psychiatric comorbidities in patients with major depressive disorder
... active major depressive episode within 2 weeks, whereas past MDD was defined as major depressive episode at any time prior to the past 2 ...
7
Prevalence of Major Depressive and Anxiety Disorders in Hemophilic and Major Beta Thalassemic Patients
... the major depressive disorder and anxiety in patients with major beta-thalassemia are more than control group, but there isn’t significant difference in hemophilic patients than ...higher ...
6
Molecular epidemiology of major depressive disorder
... outpatients with depression may be overestimated. Nier- enberg et al. [5] suggested that the actual lifetime risk of death from suicide in major depressive disorder was between 3.4 and 6%, but this estimate ...
17
Does Age at Onset of First Major Depressive Episode Indicate the Subtype of Major Depressive Disorder?: The Clinical Research Center for Depression Study
... first major depressive episode on the clinical features of individuals with ma- jor depressive disorder (MDD) in a large cohort of Korean depressed ...first major depressive episode was ...
9
Towards a Comprehensive Psychobiological Model of Major Depressive Disorder
... 2017). Major depression has become the second leading contributor to the global disability burden by 2010 (Ferrari et ...of major depressive disorder comprise genetics, stress, chronobiology, ...
19
THE ROLE OF FOLIC ACID IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
... Objective: Depressive symptoms are the most common neuropsychiatric manifestation of folic acid deficiency. The objective of this research is to determine the role of folic acid in tge treatment of major ...
8
Continuation treatment of major depressive disorder: is there a case for duloxetine?
... of major depressive ...of major depressive disorder showed that the medication was more effective than placebo in this difficult to treat ...
13
EMOTION REGULATION IN MAJOR DEPRESSIVE DISORDER
... for major depressive ...with major depressive disorder who received only drug therapy with sertraline (50- 150) mg per day were considered as the control ...
8
Effect of Xiaoyaosan on major depressive disorder
... Major depressive disorder (MDD) affects ~16% of the world population [1]. In China, the MDD prevalence is 9% in the general population, and 15–30% of all ado- lescents are estimated to be affected by the ...
7
Cutaneous leishmaniasis and co morbid major depressive disorder: A systematic review with burden estimates
... Cutaneous leishmaniasis is a highly prevalent vector-borne disease affecting large parts of Latin America and the Middle East, as well as parts of Northern Africa. There are several types of Cutaneous leishmaniasis, ...
22
Breaking the Stigma: Major Depressive Disorder
... Major Depressive Disorder (MDD) is a mood and mental disorder affecting the brain; it is caused by the reduction of three monoamine neurotransmitters: serotonin, norepinephrine, and dopamine (Rot, ...
38
Desvenlafaxine in the treatment of major depressive disorder
... Abstract: Major depressive disorder (MDD) is among the most incapacitating conditions in the ...isolated major active metabolite of venlafaxine, O-desmethylvenlafaxine: it is the third SNRI to become ...
10
Parvalbumin Promoter Methylation Altered in Major Depressive Disorder
... of major neurotransmitter systems (serotonin, catecholamine, γ-aminobutyric acid (GABA) and glutamate) have been widely reported in both MDD patients [8,9] and suicidal subjects ...
9